BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9748557)

  • 1. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health.
    Hagmar L; Bonassi S; Strömberg U; Mikoczy Z; Lando C; Hansteen IL; Montagud AH; Knudsen L; Norppa H; Reuterwall C; Tinnerberg H; Brogger A; Forni A; Högstedt B; Lambert B; Mitelman F; Nordenson I; Salomaa S; Skerfving S
    Mutat Res; 1998 Sep; 405(2):171-8. PubMed ID: 9748557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs.
    Hagmar L; Bonassi S; Strömberg U; Mikoczy Z; Lando C; Hansteen IL; Montagud AH; Knudsen L; Norppa H; Reuterwall C; Tinnerberg H; Brøgger A; Forni A; Högstedt B; Lambert B; Mitelman F; Nordenson I; Salomaa S; Skerfving S
    Recent Results Cancer Res; 1998; 154():177-84. PubMed ID: 10026999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biomarkers of cytogenetic damage in humans and risk of cancer. The European Study Group on Cytogenetic Biomarkers and Health (ESCH)].
    Lando C; Hagmar L; Bonassi S
    Med Lav; 1998; 89(2):124-31. PubMed ID: 9673102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).
    Hagmar L; Bonassi S; Strömberg U; Brøgger A; Knudsen LE; Norppa H; Reuterwall C
    Cancer Res; 1998 Sep; 58(18):4117-21. PubMed ID: 9751622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis.
    Hagmar L; Strömberg U; Tinnerberg H; Mikoczy Z
    Int J Hyg Environ Health; 2001 Oct; 204(1):43-7. PubMed ID: 11725344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nordic data base on somatic chromosome damage in humans. Nordic Study Group on the Health Risk of Chromosome Damage.
    Mutat Res; 1990 Jul; 241(3):325-37. PubMed ID: 2366811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts.
    Hagmar L; Strömberg U; Bonassi S; Hansteen IL; Knudsen LE; Lindholm C; Norppa H
    Cancer Res; 2004 Mar; 64(6):2258-63. PubMed ID: 15026371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia.
    Fucić A; Znaor A; Strnad M; van der Hel O; Aleksandrov A; Miskov S; Grah J; Sedlar M; Jazbec AM; Ceppi M; Vermeulen R; Boffetta P; Norppa H; Bonassi S
    Toxicol Lett; 2007 Jul; 172(1-2):4-11. PubMed ID: 17651925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage.
    Brøgger A; Hagmar L; Hansteen IL; Heim S; Högstedt B; Knudsen L; Lambert B; Linnainmaa K; Mitelman F; Nordenson I
    Cancer Genet Cytogenet; 1990 Mar; 45(1):85-92. PubMed ID: 2302690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.
    Bonassi S; Hagmar L; Strömberg U; Montagud AH; Tinnerberg H; Forni A; Heikkilä P; Wanders S; Wilhardt P; Hansteen IL; Knudsen LE; Norppa H
    Cancer Res; 2000 Mar; 60(6):1619-25. PubMed ID: 10749131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal aberrations and SCEs as biomarkers of cancer risk.
    Norppa H; Bonassi S; Hansteen IL; Hagmar L; Strömberg U; Rössner P; Boffetta P; Lindholm C; Gundy S; Lazutka J; Cebulska-Wasilewska A; Fabiánová E; Srám RJ; Knudsen LE; Barale R; Fucic A
    Mutat Res; 2006 Aug; 600(1-2):37-45. PubMed ID: 16814813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes.
    Bolognesi C; Abbondandolo A; Barale R; Casalone R; Dalprà L; De Ferrari M; Degrassi F; Forni A; Lamberti L; Lando C; Migliore L; Padovani P; Pasquini R; Puntoni R; Sbrana I; Stella M; Bonassi S
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):249-56. PubMed ID: 9107430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic surveillance of workers exposed to genotoxic chemicals: preliminary experiences from a prospective cancer study in a cytogenetic cohort.
    Sorsa M; Ojajärvi A; Salomaa S
    Teratog Carcinog Mutagen; 1990; 10(3):215-21. PubMed ID: 1975125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay parameters in 1, 3-butadiene-exposed workers.
    Srám RJ; Rössner P; Peltonen K; Podrazilová K; Mracková G; Demopoulos NA; Stephanou G; Vlachodimitropoulos D; Darroudi F; Tates AD
    Mutat Res; 1998 Nov; 419(1-3):145-54. PubMed ID: 9804932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer.
    Hagmar L; Strömberg U; Tinnerberg H; Mikoczy Z
    IARC Sci Publ; 2004; (157):207-15. PubMed ID: 15055297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic biomarkers.
    Norppa H
    IARC Sci Publ; 2004; (157):179-205. PubMed ID: 15055296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of intermediate endpoints in environmental and occupational health.
    Knudsen LE; Hansen AM
    Int J Hyg Environ Health; 2007 May; 210(3-4):461-70. PubMed ID: 17321211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of frequencies of HPRT mutants, chromosomal aberrations, micronuclei, sister-chromatid exchanges and cells with high frequencies of SCEs in styrene/dichloromethane-exposed workers.
    Tates AD; Grummt T; van Dam FJ; de Zwart F; Kasper FJ; Rothe R; Stirn H; Zwinderman AH; Natarajan AT
    Mutat Res; 1994; 313(2-3):249-62. PubMed ID: 7523909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage.
    Hagmar L; Brøgger A; Hansteen IL; Heim S; Högstedt B; Knudsen L; Lambert B; Linnainmaa K; Mitelman F; Nordenson I
    Cancer Res; 1994 Jun; 54(11):2919-22. PubMed ID: 8187078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs.
    Mahmoodi M; Soleyman-Jahi S; Zendehdel K; Mozdarani H; Azimi C; Farzanfar F; Safari Z; Mohagheghi MA; Khaleghian M; Divsalar K; Asgari E; Rezaei N
    Drug Chem Toxicol; 2017 Apr; 40(2):235-240. PubMed ID: 27461518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.